JENNIFER KAPLE: Open Payments
NPI 1114458163 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 27 payments from 11 companies in 2025. Trend: 2023 $730 · 2024 $893 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $175 |
| Tandem Diabetes Care, Inc. | 3 | $66 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $29 |
| CeQur Corporation | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, ISTURISA, JARDIANCE, GVOKE HYPOPEN, ZEPBOUND, CeQur Simplicity, Korlym.
Industry payments across OH — which companies pay providers there.
